Application of substance for inhibiting expression of ZNF8 protein in preparing products for preventing and treating cancer
A technology of expression quantity and product, applied in the field of biomedicine
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0086] Embodiment 1, the construction of plasmid, the preparation of oligonucleotide and the acquisition of cell
[0087] 1. Construction of Myc-ZNF8 plasmid
[0088] The small fragment between the recognition sequences of the restriction endonucleases EcoRI and XhoI of the pCMV-Myc plasmid is replaced with the DNA molecule shown in sequence 2 in the sequence listing, and the obtained recombinant plasmid is the Myc-ZNF8 plasmid.
[0089] The Myc-ZNF8 plasmid expresses the ZNF8 protein shown in Sequence 1 in the Sequence Listing.
[0090] 2. Construction of Flag-p53 plasmid
[0091] The small fragment between the recognition sequences of the restriction endonucleases EcoRI and BamHI of the pCMV-Flag plasmid is replaced with the DNA molecule shown in sequence 4 in the sequence table, and the resulting recombinant plasmid is the Flag-p53 plasmid.
[0092] The Flag-p53 plasmid expresses the p53 protein shown in sequence 3 in the sequence listing.
[0093] 3. Preparation of olig...
Embodiment 2
[0119] Embodiment 2, suppress the expression of ZNF8 protein and promote p53 protein activity
[0120] Experiment 1. Inhibiting the expression of ZNF8 protein promotes the transcriptional activity of endogenous p53 protein
[0121] The experiment was repeated three times to take the average value, and the steps for each repetition were as follows:
[0122] 1. Cells (p53 + / + HCT116 cells or p53 - / - HCT116 cells) in 6 wells of a 24-well plate containing 0.5mL DMEM medium (8.0×10 per well 4 cells), and then placed at 37°C, 5% CO 2 Culture in an incubator, and when the fusion rate reaches 70-90%, they are randomly divided into two groups, and each group is set with three replicate wells, and the following treatments are carried out:
[0123] The first group: add 20ng pG13L plasmid, 0.2ng pRL-TK plasmid and 0.4μg shNC plasmid to each well, and co-transfect for 36h.
[0124] The second group: add 20ng pG13L plasmid, 0.2ng pRL-TK plasmid and 0.4μg shZNF8-1 plasmid to each well, ...
Embodiment 3
[0139] Example 3, ZNF8 protein and p53 protein all interact under normal conditions and DNA damage conditions
[0140] Co-immunoprecipitation experiments were used to detect the interaction between ZNF8 protein and p53 protein under normal conditions and DNA damage conditions.
[0141] Experiment 1. Under normal conditions, endogenously expressed ZNF8 protein can interact with p53 protein
[0142] The experiment was repeated three times, and the steps for each repetition were as follows:
[0143] 1. Convert p53 + / + HCT116 cells were inoculated in a culture bottle containing 30 mL of DMEM medium (the size of the culture bottle was 25 cm 2 ;3.0×10 per flask 6 cells) at 37°C, 5% CO 2 Cultivate in the incubator for 48 hours (at this point the fusion rate reaches 100%).
[0144] 2. After completing step 1, add trypsin digestion solution (for the purpose of digesting the cells) into the culture flask, then transfer to a centrifuge tube (50mL), centrifuge at 1000rpm for 5min, an...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com